Vertex Pharmaceuticals Inc. buy Bank of America Co.
Start price
31.03.25
/
50%
€456.50
Target price
31.03.26
€523.00
Performance (%)
-15.62%
Price
12.12.25
€385.20
Summary
This prediction is currently active. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.62%. This prediction currently runs until 31.03.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.509% | -1.509% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Bank of America Co. from $555.00 to $567.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€377.00
19.12.24
19.12.24
€503.63
19.12.25
19.12.25
2.18%
12.12.25
12.12.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€444.75
14.10.24
14.10.24
€496.10
14.10.25
14.10.25
-20.33%
15.10.25
15.10.25